Literature DB >> 9427052

Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study.

E Sagnelli1, G B Gaeta, F M Felaco, T Stroffolini, S Conti, A Glielmo, F Piccinino, G Giusti.   

Abstract

To test the hypothesis that households of anti-HCV positive subjects might be at increased risk of HCV infection, a case-control study was carried out comparing 518 family members of 205 anti-HCV positive subjects (index carriers) with 281 family members of 100 anti-HCV negative subjects (index controls), consecutively observed in ten gastroenterology units in different Italian regions. The index carriers were age and sex matched to the index controls and their households were similar with respect to the main sociodemographic characteristics. Anti-HCV antibodies were found in 6.9% (36/518) of household members of index carriers and in 3.2% (9/281) of household members of index controls (p < 0.05). The results of multiple logistic regression analysis showed that being over 50 years of age was the sole independent predictor for a household contact of the likelihood of being anti-HCV positive (O.R. 3.6; C.I. 95% = 1.5-8.2). Being in the household of an anti-HCV index carrier was marginally associated to anti-HCV positivity (O.R. 2.0; C.I. 95% = 0.9-4.6). No association was found for sex, area of residence, family size, lowest level of schooling, or any type of family relationship. These findings are not in compliance with the statement that household contacts of HCV carriers are at increased risk of HCV infection. The 3.2% anti-HCV prevalence rate observed among household contacts of anti-HCV negative index controls may suggest that the true anti-HCV prevalence in the general population in Italy is nearly 2.5 times as high as the 1.3% found in Italian blood donors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427052     DOI: 10.1007/bf01740815

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Heterosexual transmission of hepatitis C virus in family groups without risk factors.

Authors:  G M Peano; L M Fenoglio; G Menardi; R Balbo; D Marenchino; S Fenoglio
Journal:  BMJ       Date:  1992-12-12

2.  Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver).

Authors:  M Chiaramonte; T Stroffolini; N Caporaso; R Coppola; A Craxì; G B Gaeta; E Sagnelli; A R Zanetti
Journal:  Ital J Gastroenterol       Date:  1991-12

3.  Low prevalence of anti-HCV antibodies among Italian Air Force recruits.

Authors:  R D'Amelio; T Stroffolini; P M Matricardi; R Nisini; M E Tosti; M Trematerra; U Villano; M Rapicetta; A Mele
Journal:  Scand J Infect Dis       Date:  1995

4.  High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure.

Authors:  T Stroffolini; M Menchinelli; G Taliani; V Dambruoso; G Poliandri; A Bozza; R Lecce; C Clementi; F M Ippolito; A Compagnoni
Journal:  Ital J Gastroenterol       Date:  1995-06

5.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

6.  The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study.

Authors:  D B Brettler; P M Mannucci; A Gringeri; J E Rasko; A D Forsberg; M G Rumi; R J Garsia; K A Rickard; M Colombo
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

7.  Prevalence of hepatitis C virus in family members of patients with hepatitis C.

Authors:  M Oshita; N Hayashi; A Kasahara; N Yuki; T Takehara; H Hagiwara; Y Hayakawa; Y Yasumatsuya; Y Kishida; H Fusamoto
Journal:  J Med Virol       Date:  1993-11       Impact factor: 2.327

8.  Hepatitis C virus infection in spouses of patients with type C chronic liver disease.

Authors:  Y Akahane; M Kojima; Y Sugai; M Sakamoto; Y Miyazaki; T Tanaka; F Tsuda; S Mishiro; H Okamoto; Y Miyakawa; M Mayumi
Journal:  Ann Intern Med       Date:  1994-05-01       Impact factor: 25.391

9.  Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission.

Authors:  T T Chang; T C Liou; K C Young; X Z Lin; C Y Lin; J S Shin; H L Wu
Journal:  J Med Virol       Date:  1994-01       Impact factor: 2.327

10.  Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.

Authors:  S Bellentani; C Tiribelli; G Saccoccio; M Sodde; N Fratti; C De Martin; G Cristianini
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  5 in total

1.  Intrafamilial transmission of hepatitis C virus infection.

Authors:  Eliseo Minola; Vincenzo Baldo; Tatjana Baldovin; Renzo Trivello; Annarosa Floreani
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 2.  Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review.

Authors:  Telma Thrastardottir; Thorvardur Jon Love
Journal:  Rheumatol Int       Date:  2017-11-09       Impact factor: 2.631

3.  Hepatitis C virus infection in Italian patients with fibromyalgia.

Authors:  C Palazzi; E D'Amico; S D'Angelo; A Nucera; A Petricca; I Olivieri
Journal:  Clin Rheumatol       Date:  2007-10-18       Impact factor: 2.980

4.  Hepatitis d.

Authors:  Elif S Koytak; Cihan Yurdaydin; Jeffrey S Glenn
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

5.  Correlates of HCV seropositivity among familial contacts of HCV positive patients.

Authors:  Giuseppe La Torre; Luca Miele; Alice Mannocci; Giacomina Chiaradia; Filippo Berloco; Maria L Gabrieli; Giovanni Gasbarrini; Maria Giovanna Ficarra; Antonio Matera; Gualtiero Ricciardi; Antonio Grieco
Journal:  BMC Public Health       Date:  2006-09-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.